4613347897

Muto, S., Vćtvićka, V., and Ross, G. (1993). CR3 (CDI lb/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J. Clin. Immunol. 13, 175-184.

Myers, R., Greiner, S., Harvey, M., Soeffker, D., Frenzke, M., Abraham, K., Shaw, A, Rozenblatt, S., Federspiel, M.J., Russell, S.J., and Peng, K.-W. (2005). Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer. Cancer Gene Ther. 12, 593-599.

Naik, S., and Russell, S.J. (2009). Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways. Expert Opin. Biol. Ther. 9, 1163-1176.

Naumov, G.N., Akslen, L.A., and Folkman, J. (2006). Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Celi Cycle 5, 1779-1787.

Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackbum, A., et al. (2001). Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J. Clin. Oncol. 19, 289-298.

Nguyen, T.L.-A., Abdelbary, H., Arguello, M., Breitbach, C., Leveille, S., Diallo, J.-S., Yasmeen, A., Bismar, T.A., Kim, D., Falls, T., et al. (2008). Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proceedings of the National Academy of Sciences 105, 14981-14986.

Nieswandt, B., Hafner, M., Echtenacher, B., and Mannel, D.N. (1999). Lysis of tumor cells by Natural Killer cells in mice is impeded by platelets. Cancer Res. 59, 1295-1300.

Ninomiya, H., and Sims, P.J. (1992). The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9. J. Biol. Chem. 267, 13675-13680

Norman, K.L., Hirasawa, K., Yang, A.-D., Shields, M.A., and Lee, P.W.K. (2004). Reovirus oncolysis: The Ras/RalGEF/p38 pathway dictates host celi permissiveness to reovirus infection. Proc. Natl. Acad. Sci. U. S. A. 101, 11099-11104.

Noser, J.A., Mael, A.A., Sakuma, R., Ohmine, S., Marcato, P., WK Lee, P., and Ikeda, Y. (2007). The RAS/Rafl/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: lmplication for the defective interferon response in cancer cells. Mol. Ther. 15, 1531-1536.

206